PREDICTIVE MODELING OF THERAPEUTIC RESPONSE TO CHONDROITIN SULFATE/GLUCOSAMINE HYDROCHLORIDE IN KNEE OSTEOARTHRITIS
Ontology highlight
ABSTRACT: In the present study we explored potential protein biomarkers useful to predict the therapeutic response of osteoarthritis (OA) patients treated with pharmaceutical grade Chondroitin sulfate/Glucosamine hydrochloride (CS+GH; Droglican, Bioiberica), in order to optimize therapeutic outcomes.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Blood Serum
SUBMITTER:
valentina calamia
LAB HEAD: Francisco J Blanco Garcia
PROVIDER: PXD012444 | Pride | 2019-09-12
REPOSITORIES: Pride
ACCESS DATA